These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6770974)

  • 1. Comparison of subacute effects of oxazacort and prednisone on mineral metabolism in man.
    Hahn TJ; Halstead LR; Strates B; Imbimbo B; Baran DT
    Calcif Tissue Int; 1980; 31(2):109-15. PubMed ID: 6770974
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of a new glucocorticoid, oxazacort, on some variables connected with bone metabolism in man: a comparison with prednisone.
    Caniggia A; Marchetti M; Gennari C; Vattimo A; Nicolis FB
    Int J Clin Pharmacol Biopharm; 1977 Mar; 15(3):126-34. PubMed ID: 66216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of postmenopausal hyperparathyroidism with norethindrone. Effects on biochemistry and forearm mineral density.
    Horowitz M; Wishart J; Need AG; Morris H; Philcox J; Nordin BE
    Arch Intern Med; 1987 Apr; 147(4):681-5. PubMed ID: 3827457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1alpha-hydroxychloecalciferol treatment of long-term hemodialyzed patients. Effects on mineral metabolism, bone mineral content and bone morphometry.
    Nielsen HE; Melsen F; Christensen MS; Hansen HE; Rodbro P; Johannsen A
    Clin Nephrol; 1977 Oct; 8(4):429-34. PubMed ID: 923161
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of prednisone and deflazacort on mineral metabolism and parathyroid hormone activity in humans.
    Gennari C; Imbimbo B; Montagnani M; Bernini M; Nardi P; Avioli LV
    Calcif Tissue Int; 1984 May; 36(3):245-52. PubMed ID: 6432287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mineral and bone metabolism in thyroid disease: a review.
    Auwerx J; Bouillon R
    Q J Med; 1986 Aug; 60(232):737-52. PubMed ID: 3774957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of bone mineral loss in postmenopausal women by norethisterone.
    Abdalla HI; Hart DM; Lindsay R; Leggate I; Hooke A
    Obstet Gynecol; 1985 Dec; 66(6):789-92. PubMed ID: 4069480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone collagen and calcium metabolism in normocalcemic and hypercalcemic patients with breast cancer.
    Lee CA; Lloyd HM
    Cancer; 1971 May; 27(5):1099-105. PubMed ID: 5092517
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of prolonged bed rest on bone mineral.
    Donaldson CL; Hulley SB; Vogel JM; Hattner RS; Bayers JH; McMillan DE
    Metabolism; 1970 Dec; 19(12):1071-84. PubMed ID: 4321644
    [No Abstract]   [Full Text] [Related]  

  • 10. Bone and mineral metabolism in adult celiac disease.
    Caraceni MP; Molteni N; Bardella MT; Ortolani S; Nogara A; Bianchi PA
    Am J Gastroenterol; 1988 Mar; 83(3):274-7. PubMed ID: 3257843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone mineralization and bone mineral content in primary hyperparathyroidism.
    Tougaard L; Hau C; Rodbro P; Ditzel J
    Acta Endocrinol (Copenh); 1977 Feb; 84(2):314-9. PubMed ID: 576347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of phosphate and thyrocalcitonin on skeletal turnover.
    Haddad JG; Avioli LV
    Endocrinology; 1970 Dec; 87(6):1245-50. PubMed ID: 5482702
    [No Abstract]   [Full Text] [Related]  

  • 13. Low dose prednisone does not affect calcium homeostasis or bone density in postmenopausal women with rheumatoid arthritis.
    Leboff MS; Wade JP; Mackowiak S; el-Hajj Fuleihan G; Zangari M; Liang MH
    J Rheumatol; 1991 Mar; 18(3):339-44. PubMed ID: 1856804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dialysis prescription on bone and mineral metabolism: the National Cooperative Dialysis Study.
    Harter HR; Laird NM; Teehan BP
    Kidney Int Suppl; 1983 Apr; (13):S73-9. PubMed ID: 6345900
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of prednisone on growth and bone mineral content in childhood glomerular disease.
    Chesney RW; Mazess RB; Rose P; Jax DK
    Am J Dis Child; 1978 Aug; 132(8):768-72. PubMed ID: 685891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency.
    Saggese G; Baroncelli GI; Bertelloni S; Cinquanta L; Di Nero G
    J Pediatr; 1993 Jan; 122(1):37-45. PubMed ID: 8419613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dissociation of the effects of PTH on bone matrix and calcium in rats.
    Kalu DN; Hadji-Georgopoulos A; Foster GV
    Horm Metab Res; 1975 Sep; 7(5):443-4. PubMed ID: 1183927
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of long-term maintenance therapy with a new glucocorticoid, deflazacort, on mineral metabolism and statural growth.
    Balsan S; Stéru D; Bourdeau A; Grimberg R; Lenoir G
    Calcif Tissue Int; 1987 Jun; 40(6):303-9. PubMed ID: 3111667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of high-dose glucocorticoid administration on serum bone gamma carboxyglutamic acid-containing protein, serum alkaline phosphatase and vitamin D metabolites in normal subjects.
    Nielsen HK; Thomsen K; Eriksen EF; Charles P; Storm T; Mosekilde L
    Bone Miner; 1988 Apr; 4(1):105-13. PubMed ID: 3263890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of hypervitaminosis A on the bone and mineral metabolism of the rat.
    Hough S; Avioli LV; Muir H; Gelderblom D; Jenkins G; Kurasi H; Slatopolsky E; Bergfeld MA; Teitelbaum SL
    Endocrinology; 1988 Jun; 122(6):2933-9. PubMed ID: 3371268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.